Status:
COMPLETED
Pharmacokinetics of Sufentanil After Epidural Administration
Lead Sponsor:
Poznan University of Medical Sciences
Collaborating Sponsors:
Medical University of Gdansk
Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań
Conditions:
Epidural; Anesthesia
Epidural Analgesia
Eligibility:
All Genders
18-70 years
Brief Summary
Sufentanil is an opioid analgesics used in all groups of patients. It has one of the strongest effects among analgesic drugs. Sufentanil is widely-used because of its very quick onset, short duration ...
Detailed Description
The patients qualified for abdominal surgery were enrolled in the study. All patients were premedicated with oral midazolam (7.5 mg). Epidural cannulations were placed by anesthesiologists before gene...
Eligibility Criteria
Inclusion
- age 18-70 years,
- qualifications for abdominal surgery,
- ASA I-III
Exclusion
- proven allergies to sufentanil,
- lack of written confirmed consent of a patient
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT06069219
Start Date
June 1 2019
End Date
January 31 2023
Last Update
October 5 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Heliodor Swiecicki Clinical Hospital in Poznan
Poznan, Greater Poland Voivodeship, Poland, 60-355
2
Medical University of Gdansk
Gdansk, Pomeranian Voivodeship, Poland, 80-416